MIMO Biosciences is a pioneering spin-off advancing preclinical research in hematological diseases. Our mission is to accelerate the development of innovative therapies by providing exclusive, disease-relevant animal models that closely mimic human pathology.

Our value lies in scientific excellence.
MIMO was born from the Hematology and Hemato-Oncology Lab of Dr. José Ángel Martínez-Climent at the University of Navarra and CIMA, a world-class research group with a strong track record in translational oncology.

Our scientists bring deep expertise in hematology, cancer biology, and immunotherapy, supported by high-impact publications in top journals such as Nature, Nature Medicine, Blood, and Blood Cancer Discovery.

We add value in:

* Preclinical testing of novel immuno-oncologic therapies
* Proprietary animal models that replicate human hematologic cancers
* Study design, execution, and expert data interpretation
* Scientific credibility and close collaboration with academia and industry

We provide our partners with predictive, translatable platforms that reduce risk and increase the success of early-stage drug development.

Based in Pamplona, Spain | Working globally
Let’s bring better therapies to patients—faster.






Interested in collaborating with us? Let’s talk.

MIMO Biosciences

Org chart

Teams

Offices

MIMO Biosciences

Org chart

Teams

Offices

Related companies